Search results
FDA Approves Gilead's Remdesivir For COVID-19 Treatment Patients With Severe Renal Impairment
Benzinga via Yahoo Finance· 10 months agoThe FDA approved Gilead Sciences Inc's (NASDAQ: GILD) supplemental new drug application for using...
Fewer Black Vets Got Advanced COVID Treatments at VA Hospitals During Pandemic, Study Finds
Military.com via Yahoo News· 2 years agoWhite veterans received advanced therapies for COVID-19 at higher rates than Black veterans in...
Humanigen (HGEN) Plunges as COVID Study Fails to Meet Goal
Zacks via Yahoo Finance· 2 years agoThe NIAID's ACTIV-5/BET-B study evaluating Humanigen's (HGEN) lenzilumab plus remdesivir in...
A One-Shot COVID-19 Treatment Shows Promise
Time via Yahoo News· 1 year agoCredit - Yiu Yu Hoi—Getty Images The current medicine chest for treating COVID-19 is fairly sparse. Only one drug—remdesivir—is approved by the U.S. Food...
Faulty pulse oximeter readings delayed life-saving treatments for Black COVID-19 patients, research...
INSIDER via Yahoo News· 2 years agoBlack patients waited one hour longer for access to COVID-19 treatments due to a medical device that...
Humanigen's Lenzilumab Disappoints In NIH-Backed COVID-19 Study
Benzinga via Yahoo Finance· 2 years agoHumanigen Inc (NASDAQ: HGEN) has been informed of preliminary topline results from the ACTIV-5/BET-B...
Gilead's (GILD) Q1 Earnings Miss, Veklury Sales Plunge
Zacks via Yahoo Finance· 1 year agoGilead Sciences, Inc. GILD reported lower-than-expected first-quarter results as a decline in...
Gilead (GILD) Q2 Earnings & Sales Top, Revenue Outlook Upped
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD reported strong second-quarter results driven by continued solid demand...
Gilead (GILD) Drugs Get Positive CHMP Opinion for Label Expansion
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD recently announced that the Committee for Medicinal Products for Human...
Gilead Sciences Touts Encouraging Data From Real World Studies Of Its Flagship COVID-19 Treatment
Benzinga via Yahoo Finance· 1 year agoGilead Sciences Inc (NASDAQ: GILD) announced data from three retrospective real-world Veklury...